The direct compression "gentle" heart assist device, eHeart.

Designed to heal hearts and extend lives.

How eHeart Works

heart failure

Heart disease can cause the ventricles to "unwrap."

Heart disease, often referred to as Congestive Heart Failure (CHF), is treated in three ways:

  1. Medications
  2. Surgical procedures
  3. Implantable devices

However, there is a cure: Total heart transplant. Only 2,500 are performed in the United States annually. Donor hearts are scarce.

Due to this scarcity, a patient may qualify for a Ventricular Assist Device (VAD). These devices are seen as a bridge to transplant.

The current generation of VADs have rigid patient requirements. This is why only 3,000 are implanted annually.

150,000 to 200,000 patients are either undertreated or completely untreated.

50% will die within a year after diagnosis. The majority of the others will die within five years.


Biomimicry: eHeart gently hugs the ventricles while assisting them to pump naturally.

eHeart gently applies pressure to the ventricles during their natural output cycle. This is how eHeart helps the heart to compensate for lost pumping ability. This is biomimicry at work.

Ischemic heart attack, viral or infectious disease can damage heart tissue. The heart must compensate for this lost muscle tissue. This process is called "restructuring." eHeart provides gentle compensational pumping during this process.

Every heart is different, and so is every injury to heart tissue. This is why eHeart was made with versatility in mind, offering several modes of operation. This can help return a patient to a more normal lifestyle. It also relieves stress on heart tissue which would otherwise slow or stop recovery.

The heart can rest and damaged tissue can heal.

The eHeart is designed to allow the heart to heal and extend lives.

The right and left ventricles are located at the bottom half of the heart. These are the "pumps" that send blood to the lungs and body. eHeart "Wraps" around them much like a cuff used to take your blood pressure.

eHeart has active chambers that hug the ventricles. When the heart pumps, the chambers inflate. Much like a pacemaker, the eHeart controller actively monitors this process. The heart of the patient sets the pace and eHeart picks up any slack.

eHeart pumps in direct unison with the heart. This returns normal blood flow to the heart muscle. As a result, eHeart allows it to recover from excess workload and to heal.

The versatility of eHeart allows other devices for treating heart failure to be used as well. Devices like an Implantable Cardioverter Defibrillator (ICD) or a Cardiac Resynchronization Device (CRD) may be used to complement eHeart.

eHeart is implanted without any incisions into the heart or major vessels.

Key eHeart Benefits

Mimics the heart
  • eHeart acts like the ventricles.
  • The gentle compensational pumping relieves the stress on the ailing heart.
  • Features several modes to help the heart perform and heal.
Less invasive
  • Unlike other VADs, there is no need for a surgical hole in the heart.
  • You can detach from eHeart so you can live your life.
Lower Cost
  • Less expensive than existing VADs.
  • Medicare will pay USD 160k for VAD implants (98% cost reimbursed).
  • Any patient that qualifies for a VAD implant also qualifies for an eHeart™.

Neocardial Technologies Founders

The executive management and founders of NeoCardial have extensive experience in cardio/thoracic clinical research diagnosis and surgery, general management, product development, clinical and regulatory affairs, as well as startup-to-commercialization in medical device companies.

Theodore Lillehei, M.D.

Governor, Board of Governors

Lyle D. Joyce, M.D., Ph.D.

Member, Scientific Advisory Board

Allan R. Robinson, C.C.P.

Governor, Board of Governors

Hugh McTavish, Ph.D., J.D.

Governor, Board of Governors

Brady M.A. Freeman, Esq.

Active Consultant & Governor

Michael J. Kallok, Ph.D.

Active Consultant & Governor

Neocardial Technologies Advisory Board

Thomas G. Barry Jr., Esq

Corporate Counsel
Partner, Hoff, Barry & Kozar

Jeffrey W. Bolser, RN-CV

Registered Nurse Clinician
Cardiovascular Surgical First Assistant

Steven P. Conover

President & CEO
Director of Research at AMT

Michael P. Kaye, MD

Sr. VP & Medical Director of Acumen Healthcare Solutions, LLC

William G. Lindsay, MD

Cardiothoracic Surgeon & Partner, Cardiovascular Surgeons of Minnesota

Larry R. Masterson, PhD

Assistant Professor of Chemistry, Hamline University

Scott A. Nammacher, ASA, CFA

Managing Director at Empire Valuation Consultants, LLC

John A. St. Cyr, MD, Ph.D.

Cardiovascular Surgeon

William J. Rissmann

President, Medical Innovations Product Development, LLC

Steven S. Saliterman, MD

Adjunct Professor in
Biomedical Engineering
University of Minnesota

Thomas J. Von Rueden, MD

Cardiothoracic Surgeon & Partner, Cardiovascular Surgeons of Minnesota